Cargando…
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations
The genetic mechanisms underlying disease progression, relapse and therapy resistance in mantle cell lymphoma (MCL) remain largely unknown. Whole-exome sequencing was performed in 27 MCL samples from 13 patients, representing the largest analyzed series of consecutive biopsies obtained at diagnosis...
Autores principales: | Wu, Chenglin, de Miranda, Noel FCC, Chen, Longyun, Wasik, Agata M., Mansouri, Larry, Jurczak, Wojciech, Galazka, Krystyna, Dlugosz-Danecka, Monika, Machaczka, Maciej, Zhang, Huilai, Peng, Roujun, Morin, Ryan D., Rosenquist, Richard, Sander, Birgitta, Pan-Hammarström, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122381/ https://www.ncbi.nlm.nih.gov/pubmed/27224912 http://dx.doi.org/10.18632/oncotarget.9500 |
Ejemplares similares
-
DNA repair genes are selectively mutated in diffuse large B cell lymphomas
por: de Miranda, Noel FCC, et al.
Publicado: (2013) -
Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
por: Salles, Gilles, et al.
Publicado: (2021) -
SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression
por: Wasik, Agata Magdalena, et al.
Publicado: (2013) -
Differential B-Cell Receptor Signaling Requirement for Adhesion of Mantle Cell Lymphoma Cells to Stromal Cells
por: Sadeghi, Laia, et al.
Publicado: (2020) -
The average relative dose intensity of R‐CHOP is an independent factor determining favorable overall survival in diffuse large B‐cell lymphoma patients
por: Długosz‐Danecka, Monika, et al.
Publicado: (2019)